0.33%酒石酸溴莫尼定外用凝胶可有效减轻日光激活光动力治疗后的红斑。 - Suppr

Suppr

超能文献

Topical brimonidine tartrate 0·33% gel effectively reduces the post-treatment erythema of daylight-activated photodynamic therapy.

作者信息

Gerber P A

机构信息

Department of Dermatology, Heinrich Heine University, Moorenstraße 5, 40225, Düsseldorf, Germany.

出版信息

Br J Dermatol. 2016 Jun;174(6):1422-3. doi: 10.1111/bjd.14384. Epub 2016 Mar 31.

DOI:10.1111/bjd.14384

PMID:26727630

Abstract

摘要

相似文献

Topical brimonidine tartrate 0·33% gel effectively reduces the post-treatment erythema of daylight-activated photodynamic therapy.

Br J Dermatol. 2016 Jun;174(6):1422-3. doi: 10.1111/bjd.14384. Epub 2016 Mar 31.

Allergic contact dermatitis to topical brimonidine.

Australas J Dermatol. 2015 Aug;56(3):235. doi: 10.1111/ajd.12299.

Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.

Br J Dermatol. 2012 Mar;166(3):633-41. doi: 10.1111/j.1365-2133.2011.10716.x.

Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.

J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2405-10. doi: 10.1111/jdv.13305. Epub 2015 Sep 28.

Pulse-Daylight-Photodynamic Therapy in Combination with Corticosteroid and Brimonidine Tartrate for Multiple Actinic Keratoses: A Randomized Clinical Trial.

Acta Derm Venereol. 2019 Feb 1;99(2):242-243. doi: 10.2340/00015555-3049.

Allergic contact dermatitis caused by Mirvaso®, brimonidine tartrate gel 0.33%, a new topical treatment for rosaceal erythema.

Contact Dermatitis. 2015 Dec;73(6):366-7. doi: 10.1111/cod.12476.

Topical Brimonidine Tartrate 0.33% Gel on Postlaser Erythema: Our Experience and Review of the Literature.

Dermatol Surg. 2018 Jan;44(1):144-147. doi: 10.1097/DSS.0000000000001389.

Brimonidine tartrate 0.33% gel for the management of posttreatment erythema induced by laser skin resurfacing.

J Am Acad Dermatol. 2017 Feb;76(2):e53-e55. doi: 10.1016/j.jaad.2016.10.020.

Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate-to-severe facial erythema associated with rosacea.

Br J Dermatol. 2014 Jul;171(1):162-9. doi: 10.1111/bjd.12881. Epub 2014 Jul 16.

Image Gallery: Brimonidine gel for facial erythema in Netherton syndrome.

Br J Dermatol. 2018 Apr;178(4):e277. doi: 10.1111/bjd.16355.

引用本文的文献

The burning truth about light therapy: a retrospective analysis of the MAUDE database on UV phototherapy and photodynamic therapy complications 2013-2023.

Arch Dermatol Res. 2023 Dec 18;316(1):51. doi: 10.1007/s00403-023-02765-5.

Topical Brimonidine as an Effective Adjuvant to Local Anesthetics for Post Treatment Erythema and Pain Reduction.

Ann Dermatol. 2019 Jun;31(3):315-319. doi: 10.5021/ad.2019.31.3.315. Epub 2019 May 1.

Photodynamic therapy in dermatology beyond non-melanoma cancer: An update.

Photodiagnosis Photodyn Ther. 2017 Sep;19:140-152. doi: 10.1016/j.pdpdt.2017.06.010. Epub 2017 Jun 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Topical brimonidine tartrate 0·33% gel effectively reduces the post-treatment erythema of daylight-activated photodynamic therapy.

作者信息

Gerber P A

机构信息

Department of Dermatology, Heinrich Heine University, Moorenstraße 5, 40225, Düsseldorf, Germany.

出版信息

Br J Dermatol. 2016 Jun;174(6):1422-3. doi: 10.1111/bjd.14384. Epub 2016 Mar 31.

DOI:10.1111/bjd.14384

PMID:26727630

Abstract

摘要